Venous thromboembolism in ovarian cancer: incidence, risk factors and impact on survival.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Affiliation
Department of Obstetrics & Gynaecology, Trinity Centre for Health Sciences, St. James' Hospital, Dublin 8, Ireland. Electronic address: ferasabusaadeh@dubgyn.org.Issue Date
2013-09Keywords
CANCERWOMEN'S HEALTH
Local subject classification
CANCER, OVARIANMeSH
AgedCarcinoma
Female
Humans
Incidence
Ireland
Middle Aged
Multivariate Analysis
Ovarian Neoplasms
Retrospective Studies
Risk Factors
Venous Thromboembolism
Metadata
Show full item recordCitation
Abu Saadeh F et al. Venous thromboembolism in ovarian cancer: incidence, risk factors and impact on survival. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013, 170 (1):214-8Journal
European journal of obstetrics, gynecology, and reproductive biologyDOI
10.1016/j.ejogrb.2013.06.004PubMed ID
23830352Abstract
Ovarian cancer has a higher incidence of venous thromboembolism (VTE) than other cancers. Clear cell cancers carry the highest risk at 11-27%. The aim of this study was to identify the predisposing factors for VTE in a population of ovarian cancer patients and to determine the influence of VTE on overall survival.Item Type
ArticleLanguage
enISSN
1872-7654ae974a485f413a2113503eed53cd6c53
10.1016/j.ejogrb.2013.06.004
Scopus Count
Collections
Related articles
- Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
- Authors: Fotopoulou C, duBois A, Karavas AN, Trappe R, Aminossadati B, Schmalfeldt B, Pfisterer J, Sehouli J, Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
- Issue date: 2008 Jun 1
- When 'never-events' occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes.
- Authors: Duska LR, Garrett L, Henretta M, Ferriss JS, Lee L, Horowitz N
- Issue date: 2010 Mar
- Venous thromboembolism in recurrent ovarian cancer-patients: A systematic evaluation of the North-Eastern German Society of Gynaecologic Oncology Ovarian Cancer Study Group (NOGGO).
- Authors: Fotopoulou C, Karavas A, Trappe R, Chekerov R, Lichtenegger W, Sehouli J
- Issue date: 2009 Nov
- Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma.
- Authors: Matsuo K, Hasegawa K, Yoshino K, Murakami R, Hisamatsu T, Stone RL, Previs RA, Hansen JM, Ikeda Y, Miyara A, Hiramatsu K, Enomoto T, Fujiwara K, Matsumura N, Konishi I, Roman LD, Gabra H, Fotopoulou C, Sood AK
- Issue date: 2015 Sep
- High incidence of silent venous thromboembolism before treatment in ovarian cancer.
- Authors: Satoh T, Oki A, Uno K, Sakurai M, Ochi H, Okada S, Minami R, Matsumoto K, Tanaka YO, Tsunoda H, Homma S, Yoshikawa H
- Issue date: 2007 Oct 22